Device Trial Radar · NCT03358810
Pharyngeal Electrical Stimulation Evaluation for Dysphagia After Stroke
Last checked: Nov 19, 2026Latest source record: Dec 20, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
50
Actual
Start
Mar 31, 2018
Primary completion
Jan 31, 2020
Study completion May 1, 2020
Sponsor
- Lead sponsor
- Phagenesis Ltd.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Regulatory and Clinical Research Institute Inc; Cytel Inc.
- First posted
- Dec 2, 2017
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (care provider)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 90 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a randomized, sham-controlled, patient masked, outcome assessor-blinded study to assess a Pharyngeal Electrical Stimulation (PES) Catheter for treatment of oropharyngeal dysphagia following a stroke.
Conditions
- Dysphagia Following Cerebral Infarction
Interventions
PESDevice
The PES system is a two-part neurostimulation system. It is composed of a durable component called the Base Station and the single-use sterile disposable Phagenyx® Catheter. The Base Station acts as the user interface and provides the means to generate, optimize and monitor the delivery of electrical stimulation.
Primary outcomes
What the sponsor says the trial is designed to measure.
- To evaluate the efficacy of treatment in reducing the severity of unsafe swallows based on PAS(Penetration Aspiration Scale)of each swallow during VFSSTime frame: 48 hours post final treatment
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Marianjoy
Wheaton, Illinois
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.